VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Technology Scientific & Technical Instruments

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > OH OH TOO MUCH LUBE

<< Previous

Bullboard Posts

Next >>

Comment by Pandoraon Dec 14, 2021 1:58am

112 Views

Post# 34227780

RE:RE:RE:RE:RE:RE:OH OH TOO MUCH LUBE

banderas1976 wrote: Totally wrong. Current scans 2D /3D are already rolling

should be 4D I guess!!!

Are you saying there is something wrong with this supposed blog or letter which is not dated or verified and not on the website (last I looked).

Wouldn't surprise me as it seems to be out in left field from what we have been given and it also seems strange that no one else has spoken up -- i.e. all those letter recipients.

<< Previous

Bullboard Posts

Next >>

Eminent acquires promising Nevada gold project